Kindness Begins With Inclusion
This October, our Shields family is celebrating Global Diversity Awareness Month. Over the last nine years, we have worked hard to develop and maintain Shields’s diverse and inclusive culture. We…
This October, our Shields family is celebrating Global Diversity Awareness Month. Over the last nine years, we have worked hard to develop and maintain Shields’s diverse and inclusive culture. We…
On September 15th, we hosted a panel discussion on The Evolution of Health System Specialty Pharmacy. An esteemed panel of specialty pharmacists helped us understand why a more mature specialty…
Walgreens Boots Alliance is investing $970 million for a majority stake in a specialty pharmacy company that works with hospitals and health systems to set up and run their own…
DEERFIELD, Ill. & BOSTON–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) and Shields Health Solutions today announced that WBA, through its wholly-owned subsidiary, Walgreen Co., is making a majority investment in…
The company will pay $970 million to increase its ownership of the Stoughton-based specialty pharmacy company to 71 percent
At Shields Health Solutions, improving lives and elevating performance are at the heart of everything we do, which is why we must show our support and drive better outcomes for…
Specialty pharmacy is growing, as is Shields Health Solutions and the increasing number of partners and patients we serve around the country. In this blog, we take a look at…
Dermatology is the branch of medicine concerned with the diagnosis and treatment of skin disorders. Talk to your dermatologist, a medical doctor specializing in treating the skin, hair, and nails…
Specialty pharmacists’ roles have grown in new and exciting ways in recent years, and those changes have directly impacted health outcomes for all specialty patients, including patients with HIV.
This blog was authored by the following members of our trade relations team: Kerry Mello-Parker, Director of Clinical Compliance, MJ Kelly, Medical Billing Specialist, Ben May, Director of Drug Trend…